SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle.


Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
06 2019
Historique:
received: 10 01 2019
revised: 28 02 2019
accepted: 15 03 2019
pubmed: 25 3 2019
medline: 26 11 2019
entrez: 24 3 2019
Statut: ppublish

Résumé

In addition to the central nervous system-mediated action, leptin also directly induces fatty acid oxidation in skeletal muscle. Rapid induction of FAO by leptin is mediated by the AMP-activated protein kinase (AMPK) pathway, but the mechanism of prolonged FAO by leptin was previously unknown. In an earlier study, we showed that free fatty acids increase transcription of small ubiquitin-like modifier (SUMO) specific protease 2 (SENP2) in skeletal muscle, and that SENP2 stimulates expression of FAO-associated enzymes by deSUMOylating peroxisome proliferator-activated receptors, PPARδ and PPARγ. In this study, we examine whether SENP2 is involved in prolonged stimulation of FAO by leptin. The Effect of leptin on expression of SENP2 and on SENP2-mediated FAO was investigated by using western blotting and real time qPCR of C2C12 myotubes, and of C2C12 myotubes in which expression of specific genes was knocked down using siRNAs. Additionally, muscle-specific SENP2 knockout mice were generated to test the involvement of SENP2 in leptin-induced FAO in vivo. We show that leptin treatment of C2C12 myotubes causes signal transducer and activator of transcription 3 (STAT3) to bind to the Senp2 promoter, inducing SENP2 expression. We also show that leptin increases the binding of PPARδ and PPARγ to PPRE sites in the promoters of two FAO-associated genes: long-chain acyl-CoA synthetase 1 (Acsl1) or carnitine palmitoyl transferase 1b (Cpt1b). When SENP2 is knocked down in myotubes, leptin-induced expression of FAO-associated enzymes and prolonged increase of FAO are suppressed, but rapid increase of FAO is unaffected. In addition, leptin-induced expression of FAO-associated enzymes was not observed in muscle tissue of SENP2 knockout mice. We demonstrate that the peripheral actions of leptin on FAO are mediated by two different pathways: AMPK causes a rapid increase in FAO, and SENP2 of the STAT3 pathway causes a slow, prolonged increase in FAO.

Sections du résumé

BACKGROUND AND PURPOSE
In addition to the central nervous system-mediated action, leptin also directly induces fatty acid oxidation in skeletal muscle. Rapid induction of FAO by leptin is mediated by the AMP-activated protein kinase (AMPK) pathway, but the mechanism of prolonged FAO by leptin was previously unknown. In an earlier study, we showed that free fatty acids increase transcription of small ubiquitin-like modifier (SUMO) specific protease 2 (SENP2) in skeletal muscle, and that SENP2 stimulates expression of FAO-associated enzymes by deSUMOylating peroxisome proliferator-activated receptors, PPARδ and PPARγ. In this study, we examine whether SENP2 is involved in prolonged stimulation of FAO by leptin.
METHODS
The Effect of leptin on expression of SENP2 and on SENP2-mediated FAO was investigated by using western blotting and real time qPCR of C2C12 myotubes, and of C2C12 myotubes in which expression of specific genes was knocked down using siRNAs. Additionally, muscle-specific SENP2 knockout mice were generated to test the involvement of SENP2 in leptin-induced FAO in vivo.
RESULTS
We show that leptin treatment of C2C12 myotubes causes signal transducer and activator of transcription 3 (STAT3) to bind to the Senp2 promoter, inducing SENP2 expression. We also show that leptin increases the binding of PPARδ and PPARγ to PPRE sites in the promoters of two FAO-associated genes: long-chain acyl-CoA synthetase 1 (Acsl1) or carnitine palmitoyl transferase 1b (Cpt1b). When SENP2 is knocked down in myotubes, leptin-induced expression of FAO-associated enzymes and prolonged increase of FAO are suppressed, but rapid increase of FAO is unaffected. In addition, leptin-induced expression of FAO-associated enzymes was not observed in muscle tissue of SENP2 knockout mice.
CONCLUSIONS
We demonstrate that the peripheral actions of leptin on FAO are mediated by two different pathways: AMPK causes a rapid increase in FAO, and SENP2 of the STAT3 pathway causes a slow, prolonged increase in FAO.

Identifiants

pubmed: 30902749
pii: S0026-0495(19)30060-5
doi: 10.1016/j.metabol.2019.03.004
pmc: PMC7398119
mid: NIHMS1610755
pii:
doi:

Substances chimiques

Fatty Acids 0
Leptin 0
CPT1B protein, mouse EC 2.3.1.21
Carnitine O-Palmitoyltransferase EC 2.3.1.21
AMP-Activated Protein Kinases EC 2.7.11.31
Cysteine Endopeptidases EC 3.4.22.-
Senp2 protein, mouse EC 3.4.22.68
ACSL1 protein, mouse EC 6.2.1.-
Coenzyme A Ligases EC 6.2.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-35

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK083567
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Biol Chem. 1997 Dec 19;272(51):32686-95
pubmed: 9405487
Am J Physiol. 1999 Jul;277(1):E1-10
pubmed: 10409121
Nat Rev Mol Cell Biol. 2012 Dec;13(12):755-66
pubmed: 23175280
Cell Metab. 2010 Jul 7;12(1):53-64
pubmed: 20620995
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
Cell. 2018 Jan 11;172(1-2):234-248.e17
pubmed: 29307489
Metabolism. 2019 Jan;90:52-68
pubmed: 30359677
Diabetes. 2008 May;57(5):1405-13
pubmed: 18184928
Biochem Soc Trans. 2003 Feb;31(Pt 1):196-201
pubmed: 12546684
Science. 2001 Mar 30;291(5513):2613-6
pubmed: 11283375
Annu Rev Biochem. 2004;73:355-82
pubmed: 15189146
J Physiol Biochem. 1999 Mar;55(1):43-9
pubmed: 10494659
Biochem J. 2011 Jan 1;433(1):155-61
pubmed: 20950277
PLoS One. 2014 Feb 05;9(2):e87327
pubmed: 24505284
Biochem Biophys Res Commun. 2002 Aug 16;296(2):350-4
pubmed: 12163024
Diabetes. 2015 Jan;64(1):23-35
pubmed: 25071025
Cell. 1996 Feb 9;84(3):491-5
pubmed: 8608603
Sci Rep. 2017 Nov 9;7(1):15141
pubmed: 29123236
Nature. 2002 Jan 17;415(6869):339-43
pubmed: 11797013
Biochem J. 2017 Jan 1;474(1):149-162
pubmed: 27827305
Mol Endocrinol. 2002 Apr;16(4):859-72
pubmed: 11923481
Mol Cell. 2005 Apr 1;18(1):1-12
pubmed: 15808504
Obesity (Silver Spring). 2006 Aug;14 Suppl 5:208S-212S
pubmed: 17021368
Vitam Horm. 2000;59:265-304
pubmed: 10714243
J Biol Chem. 2009 Mar 27;284(13):8223-7
pubmed: 19008217
F1000Prime Rep. 2014 Sep 04;6:73
pubmed: 25343030
Diabetes. 1997 Aug;46(8):1360-3
pubmed: 9231663
Biochim Biophys Acta. 2009 Feb;1791(2):103-9
pubmed: 19103304
Science. 1995 Jul 28;269(5223):540-3
pubmed: 7624776
Am J Physiol Endocrinol Metab. 2009 Dec;297(6):E1247-59
pubmed: 19724019
Mol Cell Biol. 2010 May;30(9):2135-46
pubmed: 20194620
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12017-22
pubmed: 17609368
J Biol Chem. 2000 May 12;275(19):14563-72
pubmed: 10799542
J Biol Chem. 2004 Jan 9;279(2):1070-9
pubmed: 14573616
Diabetes. 2015 Jul;64(7):2420-31
pubmed: 25784542
Endocrinology. 1997 Aug;138(8):3395-401
pubmed: 9231793

Auteurs

Young Do Koo (YD)

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.

Ji Seon Lee (JS)

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.

Seung-Ah Lee (SA)

Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, College of Medicine, Seoul National University, Seoul, Republic of Korea.

Paula G F Quaresma (PGF)

Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Ratan Bhat (R)

Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.

William G Haynes (WG)

Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.

Young Joo Park (YJ)

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

Young-Bum Kim (YB)

Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, College of Medicine, Seoul National University, Seoul, Republic of Korea; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Sung Soo Chung (SS)

Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: suschung@snu.ac.kr.

Kyong Soo Park (KS)

Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, College of Medicine, Seoul National University, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: kspark@snu.ac.kr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH